BOLD
Boundless Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.48
−0.80%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-97.0%
Return on equity
-86.8%
Return on assets
-103.1%
Return on invested capital
0.00x
Asset turnover
-$56.2M
Cash from operations
$3.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026